Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: old-fashioned (3), old (260), square (21)

Carboplatin(AUC2)-Paclitaxel (7 day)

Description: A chemotherapy protocol on Carboplatin (AUC2) Paclitaxel.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC2-Paclitaxel7day.pdf

Peripheral plasma exchange - patient information

Description: This factsheet is a guide to having plasma exchange treatment.
Url: /Media/UHS-website-2019/Patientinformation/Blooddisorders/Peripheral-plasma-exchange-1587-PIL.pdf

Cisplatin-Etoposide (intravenous and oral)

Description: Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CISPLATIN-ETOPOSIDE (Intravenous / Oral) Regimen SCLC – Cisplatin-Etoposide IV/PO Indication Limited stage SCLC
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Cisplatin-Etoposideintravenousandoral.pdf

Cisplatin and Gemcitabine

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-GEMCITABINE Regimen NSCLC – Cisplatin-Gemcitabine Indication Non-small cell lung cancer (in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandGemcitabinever12.pdf

Cisplatin-Etoposide (intravenous)

Description: Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CISPLATIN-ETOPOSIDE (Intravenous) Regimen SCLC – Cisplatin-Etoposide IV Indication Limited stage SCLC Usually given
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Cisplatin-Etoposideintravenous.pdf

Pemetrexed (maintenance)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) PEMETREXED (Maintenance) Regimen NSCLC – Pemetrexed (Maintenance) Indication Pemetrexed is recommended as an option
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Pemetrexedmaintenancever11.pdf

Regorafenib

Description: Chemotherapy Protocol Hepatocellular Cancer Regorafenib Regimen • Hepatocellular – Regorafenib Indication • Regorafenib is recommended as an option for treating advanced unresectable hepatocellular carcinoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Regorafenib.pdf

Topotecan (Oral)

Description: Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) TOPOTECAN (Oral) Regimen • SCLC – Topotecan PO Indication • Treatment of relapsed SCLC when re-treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Topotecan-Oral.pdf

Monoclonal antibody treatment for asthma - patient information

Description: Patient information factsheet Monoclonal antibody treatment for asthma We have sent you this factsheet because you are on the waiting list
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Monoclonal-antibody-treatment-for-asthma2320.pdf

Temozolomide (150)

Description: Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE (150) Regimen • CNS – Temozolomide (150) Indication • First line treatment of newly diagnosed glioblastoma multiforma starting
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-150.pdf

391 to 400 of 1000

Previous … 38 39 40 41 42 … Next